Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Related Citations for PubMed (Select 22286639)

1.

The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study).

Guilemany JM, García-Piñero A, Alobid I, Centellas S, Mariño FS, Valero A, Bernal-Sprekelsen M, Picado C, Mullol J.

Int Arch Allergy Immunol. 2012;158(2):184-90. doi: 10.1159/000331329. Epub 2012 Jan 26.

PMID:
22286639
2.
3.

Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.

Ciprandi G, Cirillo IG, Vizzaccaro A, Tosca MA.

Eur Ann Allergy Clin Immunol. 2005 Jan;37(1):25-9.

PMID:
15745374
4.

Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.

Segall N, Gawchik S, Georges G, Haeusler JM.

Ann Allergy Asthma Immunol. 2010 Mar;104(3):259-67. doi: 10.1016/j.anai.2009.12.003.

PMID:
20377116
5.

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.

Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G; XPERT Study Group.

J Allergy Clin Immunol. 2004 Oct;114(4):838-44.

PMID:
15480324
6.

Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation.

Guilemany JM, García-Piñero A, Alobid I, Cardelús S, Centellas S, Bartra J, Valero A, Picado C, Mullol J.

Laryngoscope. 2009 Feb;119(2):233-8. doi: 10.1002/lary.20075.

PMID:
19160389
7.

Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.

de Blic J, Wahn U, Billard E, Alt R, Pujazon MC.

Pediatr Allergy Immunol. 2005 May;16(3):267-75.

PMID:
15853959
8.

Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA.

Clin Exp Allergy. 2004 Jun;34(6):958-64.

PMID:
15196286
9.

Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.

Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.

Clin Ther. 2009 Aug;31(8):1664-87. doi: 10.1016/j.clinthera.2009.08.015. Review.

PMID:
19808127
10.

Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL.

Int Immunopharmacol. 2005 Dec;5(13-14):1800-8. Epub 2005 Jun 13.

PMID:
16275616
11.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
13.

Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.

Bautista AP, Eisenlohr CP, Lanz MJ.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):383-7. doi: 10.2500/ajra.2011.25.3668.

PMID:
22185740
14.

Efficacy and safety of levocetirizine in seasonal allergic rhinitis.

Leynadier F, Mees K, Arendt C, Pinelli ME.

Acta Otorhinolaryngol Belg. 2001;55(4):305-12.

PMID:
11859651
15.

Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.

Ciebiada M, Górska-Ciebiada M, DuBuske LM, Górski P.

Ann Allergy Asthma Immunol. 2006 Nov;97(5):664-71.

PMID:
17165277
16.

Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.

Maiti R, Rahman J, Jaida J, Allala U, Palani A.

Arch Otolaryngol Head Neck Surg. 2010 Aug;136(8):796-800. doi: 10.1001/archoto.2010.128.

PMID:
20713756
17.

Levocetirizine: a new selective H1 receptor antagonist for use in allergic disorders.

Day JH, Ellis AK, Rafeiro E.

Drugs Today (Barc). 2004 May;40(5):415-21. Review.

PMID:
15319796
18.

Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.

Patel P, Patel D.

Ann Allergy Asthma Immunol. 2008 Sep;101(3):287-94. doi: 10.1016/S1081-1206(10)60494-2.

PMID:
18814452
19.

Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis.

Barnes ML, Ward JH, Fardon TC, Lipworth BJ.

Clin Exp Allergy. 2006 May;36(5):676-84.

PMID:
16650054
20.

A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis.

Badorrek P, Dick M, Schauerte A, Hecker H, Murdoch R, Luettig B, Hohlfeld JM, Krug N.

Int J Clin Pharmacol Ther. 2009 Feb;47(2):71-7. Erratum in: Int J Clin Pharmacol Ther. 2009 Mar;47(3):222.

PMID:
19203562
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk